175 related articles for article (PubMed ID: 16433585)
1. Duloxetine in diabetic neuropathy.
Smith TR
Expert Opin Pharmacother; 2006 Feb; 7(2):215-23. PubMed ID: 16433585
[TBL] [Abstract][Full Text] [Related]
2. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
Smith T; Nicholson RA
Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
[TBL] [Abstract][Full Text] [Related]
3. Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.
Kinoshita J; Takahashi Y; Watabe AM; Utsunomiya K; Kato F
Mol Pain; 2013 Nov; 9():59. PubMed ID: 24279796
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine vs. placebo in patients with painful diabetic neuropathy.
Goldstein DJ; Lu Y; Detke MJ; Lee TC; Iyengar S
Pain; 2005 Jul; 116(1-2):109-18. PubMed ID: 15927394
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine: a new selective and dual-acting antidepressant.
Bauer M; Möller HJ; Schneider E
Expert Opin Pharmacother; 2006 Mar; 7(4):421-7. PubMed ID: 16503814
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
Westanmo AD; Gayken J; Haight R
Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
[TBL] [Abstract][Full Text] [Related]
7. Safety and adverse event profile of duloxetine.
Wernicke JF; Gahimer J; Yalcin I; Wulster-Radcliffe M; Viktrup L
Expert Opin Drug Saf; 2005 Nov; 4(6):987-93. PubMed ID: 16255658
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
[TBL] [Abstract][Full Text] [Related]
9. [Duloxetine, a new therapeutic option for diabetic peripheral neuropathic pain].
Ziegler D
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S284-8. PubMed ID: 17139588
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects.
Prescrire Int; 2006 Oct; 15(85):168-72. PubMed ID: 17121211
[TBL] [Abstract][Full Text] [Related]
11. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
Thor KB; Kirby M; Viktrup L
Int J Clin Pract; 2007 Aug; 61(8):1349-55. PubMed ID: 17608681
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
Zinner NR
Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
[TBL] [Abstract][Full Text] [Related]
14. A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
Mixcoatl-Zecuatl T; Jolivalt CG
Br J Pharmacol; 2011 Sep; 164(1):159-69. PubMed ID: 21410686
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
Wernicke J; Lledó A; Raskin J; Kajdasz DK; Wang F
Drug Saf; 2007; 30(5):437-55. PubMed ID: 17472422
[TBL] [Abstract][Full Text] [Related]
16. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine--three birds with one stone?
Michel MC
Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
[No Abstract] [Full Text] [Related]
18. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.
Raskin J; Wang F; Pritchett YL; Goldstein DJ
Pain Med; 2006; 7(5):373-85. PubMed ID: 17014595
[TBL] [Abstract][Full Text] [Related]
19. Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain.
Kuhad A; Bishnoi M; Chopra K
Indian J Exp Biol; 2009 Mar; 47(3):193-7. PubMed ID: 19405385
[TBL] [Abstract][Full Text] [Related]
20. [Expel the fear of pain. Breaking of chronicity by re-learning].
Ameri AA
MMW Fortschr Med; 2009 Dec; 151(51-52):51-3. PubMed ID: 20088327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
